This paper examines the incremental cost-effectiveness of a strategy to promote the use of oral rehydration solution and zinc supplementation for the management of acute diarrhea in children under 5 years through social franchising compared to standard government and private sector practices. The study uses cost and outcome data from an initiative by PSI in 3 townships of Myanmar in 2010 to promote an ORS-Zinc product called ORASEL.
Findings suggested that investing in developing a network of private sector providers and keeping them stocked with ORS-Z as is done in a social franchise can be a highly cost-effective in terms of dollars per DALY averted.